SCHEMBL3934646

SCHEMBL3934646

NC(=O)c1ccc(-c2ccc(Cl)c(C(=O)O)c2)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.55
MKNK2 Q9HBH9 1/20 0.55
GRIK1 P39086 1/20 0.53
GRIA1 P42261 1/20 0.53
GRIA2 P42262 1/20 0.53
GRIA3 P42263 1/20 0.53
GRIA4 P48058 1/20 0.53
GRIK2 Q13002 1/20 0.53
GRIK3 Q13003 1/20 0.53
ALDH1A1 P00352 1/20 0.52
TP53 P04637 1/20 0.52
PDK2 Q15119 2/20 0.49
XDH P47989 2/20 0.49
KDM4E B2RXH2 2/20 0.49
NPC1 O15118 2/20 0.49
POLB P06746 2/20 0.49
RAB9A P51151 2/20 0.49
MAPT P10636 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
KMT2A Q03164 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2771204 0.85 ALDH1A1 (0.68) GRIK1GRIA1GRIA2GRIA3GRIA4
SCHEMBL2770320 0.81 TSHR (0.68) MKNK1MKNK2GRIK1GRIA1GRIA2
SCHEMBL29684183 0.79 KMT2A (0.59) MKNK1MKNK2ALDH1A1KDM4EMAPT
SCHEMBL30732489 0.79 KMT2A (0.59) MKNK1MKNK2ALDH1A1KDM4EMAPT
SCHEMBL7281430 0.79 MKNK2 (0.58) MKNK1MKNK2PDK2XDHKMT2A
SCHEMBL122520 0.78 ACMSD (0.63) GRIK1GRIA1GRIA2GRIA3GRIA4
SCHEMBL4736986 0.76 MKNK1 (0.43) MKNK1MKNK2ALDH1A1TP53PDK2
SCHEMBL2555818 0.76 GRIK1 (0.53) GRIK1GRIA1GRIA2GRIA3GRIA4
SCHEMBL3128937 0.75 GRIK1 (0.55) GRIK1GRIA1GRIA2GRIA3GRIA4
SCHEMBL27614869 0.74 AHR (0.50) MKNK1MKNK2GRIK1GRIA1GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082372-A1 Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols BAYER SCHERING PHARMA AG (DE) 2009-03-26 US disclosed
WO-2009013354-A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082372-A1 Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols FSHR, SHBG, NAT1 MKNK1 3469/4885MKNK2 2728/4885GRIK1 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.